Silver nanoparticles for drug delivery:
Silver Nanoparticles for Drug Delivery is a complete reference that provides comprehensive coverage of the principle behind the formation, characterization, application, regulation, toxicity, and challenges and future perspectives of silver nanoparticles in drug delivery for the treatment of various...
Gespeichert in:
| Weitere Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
London
Academic Press
[2024]
|
| Schlagworte: | |
| Zusammenfassung: | Silver Nanoparticles for Drug Delivery is a complete reference that provides comprehensive coverage of the principle behind the formation, characterization, application, regulation, toxicity, and challenges and future perspectives of silver nanoparticles in drug delivery for the treatment of various diseases. Sections cover the synthesis and characterization of silver nanoparticles (AgNPs), historical introductions to developments, methods and characterization parameters, green and biological synthesis methods, biofate and cellular interactions of AgNPs, drug delivery for the treatment of several diseases and conditions, targeting strategies, applications in cancer diagnosis and treatment, and much more. This is a complete reference for graduate students in nanotechnology drug delivery |
| Beschreibung: | Preface; Part A: Synthesis and characterization of silver nanoparticles; for drug delivery; 1. History, introduction, and physicochemical properties of silver nanoparticles; 2. Synthesis methods and characterization parameters of silver nanoparticles; Part B: Application of silver nanoparticles in drug delivery; 3. Targeting strategies and clinical implications of bio-conjugated silver nanoparticles in drug delivery; 4. Silver nanoparticles for pharmaceutical and biomedical applications drug delivery; 5. Silver nanoparticles for cancer diagnosis and treatment of cancer; 6. Silver nanoparticles to enhance photodynamic action of photosensitizers; 7. Silver nanoparticles against multidrug-resistant bacteria and bacterial biofilm; 8. Silver nanoparticles in wound therapy and tissue regeneration; 9. Silver nanoparticles for drug delivery in inflammatory bowel disease; 10. Silver nanoparticles for the management of neurological diseases; 11. Nutritional plants, phytochemicals, microorganisms-derived silver nanoparticles and their diabetic managements; 12. Silver nanoparticles in dentistry; 13. Silver nanoparticles and their role in the treatment of endodontic infections; 14. Silver nanoparticles for treatment of COVID-19 and other viral diseases; Part C: Recent advances and regulatory aspects of silver nanoparticles; 15. Biological toxicity, safety issues, and environmental hazards associated with silver nanoparticles; 16. Silver nanoparticleinduced ecotoxicity; 17. Clinical translation of silver nanoparticles into the market; 18. Conclusion and future prospective of silver nanoparticles |
| Beschreibung: | xxiii, 475 Seiten Illustrationen, Diagramme 450 gr |
| ISBN: | 9780443153433 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV049465531 | ||
| 003 | DE-604 | ||
| 005 | 20240416 | ||
| 007 | t | ||
| 008 | 231213s2024 a||| |||| 00||| eng d | ||
| 020 | |a 9780443153433 |9 978-0-443-15343-3 | ||
| 024 | 3 | |a 9780443153433 | |
| 035 | |a (OCoLC)1430766656 | ||
| 035 | |a (DE-599)BVBBV049465531 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-29T | ||
| 245 | 1 | 0 | |a Silver nanoparticles for drug delivery |c edited by Prashant Kesharwani |
| 264 | 1 | |a London |b Academic Press |c [2024] | |
| 300 | |a xxiii, 475 Seiten |b Illustrationen, Diagramme |c 450 gr | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 500 | |a Preface; Part A: Synthesis and characterization of silver nanoparticles; for drug delivery; 1. History, introduction, and physicochemical properties of silver nanoparticles; 2. Synthesis methods and characterization parameters of silver nanoparticles; Part B: Application of silver nanoparticles in drug delivery; 3. Targeting strategies and clinical implications of bio-conjugated silver nanoparticles in drug delivery; 4. Silver nanoparticles for pharmaceutical and biomedical applications drug delivery; 5. Silver nanoparticles for cancer diagnosis and treatment of cancer; 6. Silver nanoparticles to enhance photodynamic action of photosensitizers; 7. Silver nanoparticles against multidrug-resistant bacteria and bacterial biofilm; 8. Silver nanoparticles in wound therapy and tissue regeneration; 9. Silver nanoparticles for drug delivery in inflammatory bowel disease; 10. Silver nanoparticles for the management of neurological diseases; 11. Nutritional plants, phytochemicals, microorganisms-derived silver nanoparticles and their diabetic managements; 12. Silver nanoparticles in dentistry; 13. Silver nanoparticles and their role in the treatment of endodontic infections; 14. Silver nanoparticles for treatment of COVID-19 and other viral diseases; Part C: Recent advances and regulatory aspects of silver nanoparticles; 15. Biological toxicity, safety issues, and environmental hazards associated with silver nanoparticles; 16. Silver nanoparticleinduced ecotoxicity; 17. Clinical translation of silver nanoparticles into the market; 18. Conclusion and future prospective of silver nanoparticles | ||
| 520 | |a Silver Nanoparticles for Drug Delivery is a complete reference that provides comprehensive coverage of the principle behind the formation, characterization, application, regulation, toxicity, and challenges and future perspectives of silver nanoparticles in drug delivery for the treatment of various diseases. Sections cover the synthesis and characterization of silver nanoparticles (AgNPs), historical introductions to developments, methods and characterization parameters, green and biological synthesis methods, biofate and cellular interactions of AgNPs, drug delivery for the treatment of several diseases and conditions, targeting strategies, applications in cancer diagnosis and treatment, and much more. This is a complete reference for graduate students in nanotechnology drug delivery | ||
| 650 | 4 | |a bicssc | |
| 650 | 4 | |a bisacsh | |
| 700 | 1 | |a Kesharwani, Prashant |0 (DE-588)1233370847 |4 edt | |
Datensatz im Suchindex
| _version_ | 1805071282927042560 |
|---|---|
| adam_text | |
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author2 | Kesharwani, Prashant |
| author2_role | edt |
| author2_variant | p k pk |
| author_GND | (DE-588)1233370847 |
| author_facet | Kesharwani, Prashant |
| building | Verbundindex |
| bvnumber | BV049465531 |
| ctrlnum | (OCoLC)1430766656 (DE-599)BVBBV049465531 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000 c 4500</leader><controlfield tag="001">BV049465531</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20240416</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">231213s2024 a||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780443153433</subfield><subfield code="9">978-0-443-15343-3</subfield></datafield><datafield tag="024" ind1="3" ind2=" "><subfield code="a">9780443153433</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1430766656</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV049465531</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-29T</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Silver nanoparticles for drug delivery</subfield><subfield code="c">edited by Prashant Kesharwani</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London</subfield><subfield code="b">Academic Press</subfield><subfield code="c">[2024]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xxiii, 475 Seiten</subfield><subfield code="b">Illustrationen, Diagramme</subfield><subfield code="c">450 gr</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Preface; Part A: Synthesis and characterization of silver nanoparticles; for drug delivery; 1. History, introduction, and physicochemical properties of silver nanoparticles; 2. Synthesis methods and characterization parameters of silver nanoparticles; Part B: Application of silver nanoparticles in drug delivery; 3. Targeting strategies and clinical implications of bio-conjugated silver nanoparticles in drug delivery; 4. Silver nanoparticles for pharmaceutical and biomedical applications drug delivery; 5. Silver nanoparticles for cancer diagnosis and treatment of cancer; 6. Silver nanoparticles to enhance photodynamic action of photosensitizers; 7. Silver nanoparticles against multidrug-resistant bacteria and bacterial biofilm; 8. Silver nanoparticles in wound therapy and tissue regeneration; 9. Silver nanoparticles for drug delivery in inflammatory bowel disease; 10. Silver nanoparticles for the management of neurological diseases; 11. Nutritional plants, phytochemicals, microorganisms-derived silver nanoparticles and their diabetic managements; 12. Silver nanoparticles in dentistry; 13. Silver nanoparticles and their role in the treatment of endodontic infections; 14. Silver nanoparticles for treatment of COVID-19 and other viral diseases; Part C: Recent advances and regulatory aspects of silver nanoparticles; 15. Biological toxicity, safety issues, and environmental hazards associated with silver nanoparticles; 16. Silver nanoparticleinduced ecotoxicity; 17. Clinical translation of silver nanoparticles into the market; 18. Conclusion and future prospective of silver nanoparticles</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Silver Nanoparticles for Drug Delivery is a complete reference that provides comprehensive coverage of the principle behind the formation, characterization, application, regulation, toxicity, and challenges and future perspectives of silver nanoparticles in drug delivery for the treatment of various diseases. Sections cover the synthesis and characterization of silver nanoparticles (AgNPs), historical introductions to developments, methods and characterization parameters, green and biological synthesis methods, biofate and cellular interactions of AgNPs, drug delivery for the treatment of several diseases and conditions, targeting strategies, applications in cancer diagnosis and treatment, and much more. This is a complete reference for graduate students in nanotechnology drug delivery</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">bicssc</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">bisacsh</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kesharwani, Prashant</subfield><subfield code="0">(DE-588)1233370847</subfield><subfield code="4">edt</subfield></datafield></record></collection> |
| id | DE-604.BV049465531 |
| illustrated | Illustrated |
| index_date | 2024-07-03T23:15:44Z |
| indexdate | 2024-07-20T04:35:21Z |
| institution | BVB |
| isbn | 9780443153433 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-034811206 |
| oclc_num | 1430766656 |
| open_access_boolean | |
| owner | DE-29T |
| owner_facet | DE-29T |
| physical | xxiii, 475 Seiten Illustrationen, Diagramme 450 gr |
| publishDate | 2024 |
| publishDateSearch | 2024 |
| publishDateSort | 2024 |
| publisher | Academic Press |
| record_format | marc |
| spelling | Silver nanoparticles for drug delivery edited by Prashant Kesharwani London Academic Press [2024] xxiii, 475 Seiten Illustrationen, Diagramme 450 gr txt rdacontent n rdamedia nc rdacarrier Preface; Part A: Synthesis and characterization of silver nanoparticles; for drug delivery; 1. History, introduction, and physicochemical properties of silver nanoparticles; 2. Synthesis methods and characterization parameters of silver nanoparticles; Part B: Application of silver nanoparticles in drug delivery; 3. Targeting strategies and clinical implications of bio-conjugated silver nanoparticles in drug delivery; 4. Silver nanoparticles for pharmaceutical and biomedical applications drug delivery; 5. Silver nanoparticles for cancer diagnosis and treatment of cancer; 6. Silver nanoparticles to enhance photodynamic action of photosensitizers; 7. Silver nanoparticles against multidrug-resistant bacteria and bacterial biofilm; 8. Silver nanoparticles in wound therapy and tissue regeneration; 9. Silver nanoparticles for drug delivery in inflammatory bowel disease; 10. Silver nanoparticles for the management of neurological diseases; 11. Nutritional plants, phytochemicals, microorganisms-derived silver nanoparticles and their diabetic managements; 12. Silver nanoparticles in dentistry; 13. Silver nanoparticles and their role in the treatment of endodontic infections; 14. Silver nanoparticles for treatment of COVID-19 and other viral diseases; Part C: Recent advances and regulatory aspects of silver nanoparticles; 15. Biological toxicity, safety issues, and environmental hazards associated with silver nanoparticles; 16. Silver nanoparticleinduced ecotoxicity; 17. Clinical translation of silver nanoparticles into the market; 18. Conclusion and future prospective of silver nanoparticles Silver Nanoparticles for Drug Delivery is a complete reference that provides comprehensive coverage of the principle behind the formation, characterization, application, regulation, toxicity, and challenges and future perspectives of silver nanoparticles in drug delivery for the treatment of various diseases. Sections cover the synthesis and characterization of silver nanoparticles (AgNPs), historical introductions to developments, methods and characterization parameters, green and biological synthesis methods, biofate and cellular interactions of AgNPs, drug delivery for the treatment of several diseases and conditions, targeting strategies, applications in cancer diagnosis and treatment, and much more. This is a complete reference for graduate students in nanotechnology drug delivery bicssc bisacsh Kesharwani, Prashant (DE-588)1233370847 edt |
| spellingShingle | Silver nanoparticles for drug delivery bicssc bisacsh |
| title | Silver nanoparticles for drug delivery |
| title_auth | Silver nanoparticles for drug delivery |
| title_exact_search | Silver nanoparticles for drug delivery |
| title_exact_search_txtP | Silver nanoparticles for drug delivery |
| title_full | Silver nanoparticles for drug delivery edited by Prashant Kesharwani |
| title_fullStr | Silver nanoparticles for drug delivery edited by Prashant Kesharwani |
| title_full_unstemmed | Silver nanoparticles for drug delivery edited by Prashant Kesharwani |
| title_short | Silver nanoparticles for drug delivery |
| title_sort | silver nanoparticles for drug delivery |
| topic | bicssc bisacsh |
| topic_facet | bicssc bisacsh |
| work_keys_str_mv | AT kesharwaniprashant silvernanoparticlesfordrugdelivery |